Kolgroups

Front Row Partners LLC is a boutique consulting firm based in Boston, MA, specializing in strategic business partnerships and advisory services. With a focus on fostering collaborative relationships and driving growth for clients, the company offers tailored solutions to meet the unique needs of each organization. Generated from their business information

Dacp in Boston, MA is a renowned Department of Population Medicine affiliated with Harvard Medical School and Harvard Pilgrim. With a focus on population health, their research spans various divisions and centers, including Chronic Disease Research Across the Lifecourse, Health Policy and Insurance Research, Biostatistics, Child Health Research and Policy, and Therapeutics Research and Infectious Disease Epidemiology. They are also home to three Centers of Excellence, fostering collaboration among faculty and promoting their expertise to the outside world. Dacp has been at the forefront of innovation for over 25 years, making significant impacts in the field. In addition to their research endeavors, they provide teaching and training opportunities for physicians and population scientists, equipping them with the tools to become future leaders in healthcare. Their commitment to advancing knowledge and improving population health sets them apart as a leading institution in the field of population medicine.Generated from the website

Anagenesis Biotherapies Inc., a subsidiary of Anagenesis Biotechnologies, is located in Boston, Massachusetts, primarily focusing on the development of stem cell-derived treatments for muscle diseases. Established in April 2016, the company is initially targeting Duchenne Muscular Dystrophy (DMD), with plans for future partnerships in the field of cell therapy. Operating from the innovative Cambridge Innovation Center at 50 Milk Street, Anagenesis Biotherapies aims to advance its cell therapy programs and contribute significantly to the life sciences sector in Massachusetts. The company's commitment to addressing serious muscle diseases underscores its role in the evolving biotechnology landscape. Generated from the website